Michelle C. Fox

1.1k total citations
29 papers, 831 citations indexed

About

Michelle C. Fox is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Obstetrics and Gynecology. According to data from OpenAlex, Michelle C. Fox has authored 29 papers receiving a total of 831 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 10 papers in Pediatrics, Perinatology and Child Health and 8 papers in Obstetrics and Gynecology. Recurrent topics in Michelle C. Fox's work include Reproductive Health and Contraception (18 papers), Maternal and fetal healthcare (8 papers) and Maternal and Perinatal Health Interventions (7 papers). Michelle C. Fox is often cited by papers focused on Reproductive Health and Contraception (18 papers), Maternal and fetal healthcare (8 papers) and Maternal and Perinatal Health Interventions (7 papers). Michelle C. Fox collaborates with scholars based in United States, United Kingdom and Germany. Michelle C. Fox's co-authors include Mitchell D. Creinin, Colleen M. Krajewski, Louise E. Purton, Shangqin Guo, Bradley S. Cobb, Hao Zhang, Jun Lü, David T. Scadden, Matthias Merkenschlager and Todd R. Golub and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Michelle C. Fox

28 papers receiving 793 citations

Peers

Michelle C. Fox

PHEOH

PPCH

Michelle Wise New Zealand

Alexandra J. Umbers Australia

Jo‐Ann Brock Canada

Sue Yazaki Sun Brazil

Devereux N. Saller United States

Ofer Lehavi Israel

Stylianos Michalas Greece

Allan T. Bombard United States

Karine Chung United States

B. Polliotti United States

Michelle Wise New Zealand

Michelle C. Fox

219 ×0.4

PHEOH

125 ×0.4

PPCH

486 ×1.9

140 ×0.7

53 ×0.3

Citations per year, relative to Michelle C. Fox Michelle C. Fox (= 1×) peers Michelle Wise

Countries citing papers authored by Michelle C. Fox

Since Specialization

Citations

This map shows the geographic impact of Michelle C. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle C. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle C. Fox more than expected).

Fields of papers citing papers by Michelle C. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle C. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle C. Fox. The network helps show where Michelle C. Fox may publish in the future.

Co-authorship network of co-authors of Michelle C. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle C. Fox. A scholar is included among the top collaborators of Michelle C. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle C. Fox. Michelle C. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rockstroh, Jürgen K., Roger Paredes, Pedro Cahn, et al.. (2025). Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial. Clinical Infectious Diseases. 81(2). 322–332.

Mills, Anthony, Giuliano Rizzardini, Moti Ramgopal, et al.. (2024). Switch to fixed-dose doravirine (100 mg) with islatravir (0·75 mg) once daily in virologically suppressed adults with HIV-1 on bictegravir, emtricitabine, and tenofovir alafenamide: 48-week results of a phase 3, randomised, controlled, double-blind, non-inferiority trial. The Lancet HIV. 11(6). e357–e368. 8 indexed citations

Mansour, Diana, Ian S. Fraser, Alison Edelman, et al.. (2019). Can initial vaginal bleeding patterns in etonogestrel implant users predict subsequent bleeding in the first 2 years of use?. Contraception. 100(4). 264–268. 11 indexed citations

Iwanaga, Joe, Michelle C. Fox, Hans Rekers, Lisa Barrie Schwartz, & R. Shane Tubbs. (2019). Neurovascular anatomy of the adult female medial arm in relationship to potential sites for insertion of the etonogestrel contraceptive implant. Contraception. 100(1). 26–30. 13 indexed citations

Reed, Suzanne, et al.. (2019). Real world data on Nexplanon® procedure-related events: final results from the Nexplanon Observational Risk Assessment study (NORA). Contraception. 100(1). 31–36. 29 indexed citations

Fox, Michelle C., Christine Klipping, Allison Martin Nguyen, et al.. (2018). A phase 2b multicenter, randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of vaginal rings containing nomegestrol acetate or etonogestrel and 17β-estradiol in the treatment of women with primary dysmenorrhea. Contraception. 99(2). 125–130. 5 indexed citations

Feldman, Robert, et al.. (2016). Safety and efficacy of the NuvaRing® Applicator in healthy females: a multicenter, open-label, randomized, 2-period crossover study. Contraception. 94(4). 362–365. 3 indexed citations

Woo, Irene, et al.. (2015). Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices. Contraception. 92(6). 532–535. 33 indexed citations

Perritt, Jamila, et al.. (2012). Contraception counseling, pregnancy intention and contraception use in women with medical problems: an analysis of data from the Maryland Pregnancy Risk Assessment Monitoring System (PRAMS). Contraception. 88(2). 263–268. 30 indexed citations

10.

Guo, Shangqin, Jun Lü, Hao Zhang, et al.. (2010). MicroRNA miR-125a controls hematopoietic stem cell number. Proceedings of the National Academy of Sciences. 107(32). 14229–14234. 260 indexed citations

11.

Fox, Michelle C., et al.. (2010). Immediate placement of intrauterine devices after first and second trimester pregnancy termination. Contraception. 83(1). 34–40. 43 indexed citations

12.

Bakhru, Arvind, Julie B. Mallinger, & Michelle C. Fox. (2010). Postexposure prophylaxis for victims of sexual assault: treatments and attitudes of emergency department physicians. Contraception. 82(2). 168–173. 12 indexed citations

13.

Hayes, Jennifer L. & Michelle C. Fox. (2009). Cervical Dilation in Second-Trimester Abortion. Clinical Obstetrics & Gynecology. 52(2). 171–178. 12 indexed citations

14.

Reeves, Matthew F., Michelle C. Fox, Patricia A. Lohr, & Mitchell D. Creinin. (2009). Endometrial thickness following medical abortion is not predictive of subsequent surgical intervention. Ultrasound in Obstetrics and Gynecology. 34(1). 104–109. 45 indexed citations

15.

Creinin, Mitchell D., Michelle C. Fox, Stephanie Teal, et al.. (2004). A Randomized Comparison of Misoprostol 6 to 8 Hours Versus 24 Hours After Mifepristone for Abortion. Obstetrics and Gynecology. 103(5, Part 1). 851–859. 78 indexed citations

16.

Fox, Michelle C., et al.. (2003). Feasibility study of the use of a daily electronic mail reminder to improve oral contraceptive compliance. Contraception. 68(5). 365–371. 22 indexed citations

17.

Fox, Michelle C. & Mitchell D. Creinin. (2002). Modern management of first trimester miscarriage. 2(1). 47–58. 1 indexed citations

18.

Fox, Michelle C., Mitchell D. Creinin, & Bryna Harwood. (2002). Mifepristone and vaginal misoprostol on the same day for abortion from 50 to 63 days’ gestation. Contraception. 66(4). 225–229. 17 indexed citations

19.

Paul, Maureen, et al.. (2002). Early surgical abortion: Efficacy and safety. American Journal of Obstetrics and Gynecology. 187(2). 407–411. 53 indexed citations

20.

Paul, Maureen, et al.. (2002). Is Pathology Examination Useful After Early Surgical Abortion?. Obstetrics and Gynecology. 99(4). 567–571. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact